Qualgen, LLC, #1-M-4255/#1-B-4469 – Case No. 1408: Admitted
to guilt on 65 counts including failing to have and follow a diversion
detection and prevention plan that includes all prescription drugs;
engaging in the manufacturing of drugs and selling, bartering, brokering,
or transferring drugs to a person not authorized to purchase drugs;
and failing to include on the label of the drug the statement “Not for
Resale” and, if the drug is dispensed or distributed other than pursuant
to a prescription for an individual identified patient, the statement
“Office Use Only.” Respondent neither admits nor denies guilt on the
remaining 978 counts. $100,000 fine. License placed on probation
for five years until June 15, 2021.
source Oklahoma Board of Pharmacy October 2016 Newsletter
source Oklahoma Board of Pharmacy October 2016 Newsletter
No comments:
Post a Comment